Ofatumumab

Definition: Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions. Under the brand name Arzerra, it is approved for the treatment of certain types of chronic lymphocytic leukemia (CLL) in the United States. source: Wikipedia

ID

444607009

ID date

7 Oct 2010

Previous ID

16750311000001109

Name

Ofatumumab